OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Cell Reports (2022) Vol. 38, Iss. 1, pp. 110190-110190
Open Access | Times Cited: 75
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Cell Reports (2022) Vol. 38, Iss. 1, pp. 110190-110190
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Epidemiology of Renal Cell Carcinoma: 2022 Update
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 405
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 405
Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology
Carmine Settembre, Rushika M. Perera
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 223-245
Closed Access | Times Cited: 88
Carmine Settembre, Rushika M. Perera
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 223-245
Closed Access | Times Cited: 88
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
Nicola Alesi, Damir Khabibullin, Dean M. Rosenthal, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Nicola Alesi, Damir Khabibullin, Dean M. Rosenthal, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma
Jiao Li, Kaimeng Huang, Meha Thakur, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 3
Jiao Li, Kaimeng Huang, Meha Thakur, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 3
A central role for regulated protein stability in the control of TFE3 and MITF by nutrients
Christopher Nardone, Brad A. Palanski, Daniel C. Scott, et al.
Molecular Cell (2023) Vol. 83, Iss. 1, pp. 57-73.e9
Open Access | Times Cited: 27
Christopher Nardone, Brad A. Palanski, Daniel C. Scott, et al.
Molecular Cell (2023) Vol. 83, Iss. 1, pp. 57-73.e9
Open Access | Times Cited: 27
Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis
Gopinath Prakasam, Akhilesh Mishra, Alana Christie, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 14
Gopinath Prakasam, Akhilesh Mishra, Alana Christie, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 14
Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas
Justin W. Miller, Jeffrey S. Johnson, Christopher Guske, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 326-326
Open Access | Times Cited: 1
Justin W. Miller, Jeffrey S. Johnson, Christopher Guske, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 326-326
Open Access | Times Cited: 1
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers
Daniela Perotti, Maureen J. O’Sullivan, Amy L. Walz, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Daniela Perotti, Maureen J. O’Sullivan, Amy L. Walz, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification
Mimma Rizzo, Anna Caliò, Matteo Brunelli, et al.
Cancer Treatment Reviews (2023) Vol. 116, pp. 102558-102558
Closed Access | Times Cited: 21
Mimma Rizzo, Anna Caliò, Matteo Brunelli, et al.
Cancer Treatment Reviews (2023) Vol. 116, pp. 102558-102558
Closed Access | Times Cited: 21
A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
Mingkee Achom, Ananthan Sadagopan, Chunyang Bao, et al.
Cell (2024) Vol. 187, Iss. 20, pp. 5735-5752.e25
Closed Access | Times Cited: 8
Mingkee Achom, Ananthan Sadagopan, Chunyang Bao, et al.
Cell (2024) Vol. 187, Iss. 20, pp. 5735-5752.e25
Closed Access | Times Cited: 8
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma
Arnav Srivastava, Sai Krishnaraya Doppalapudi, Hiren V. Patel, et al.
Current Opinion in Oncology (2022) Vol. 34, Iss. 3, pp. 234-242
Open Access | Times Cited: 24
Arnav Srivastava, Sai Krishnaraya Doppalapudi, Hiren V. Patel, et al.
Current Opinion in Oncology (2022) Vol. 34, Iss. 3, pp. 234-242
Open Access | Times Cited: 24
Emerging roles of the MiT/TFE factors in cancer
Roberto Zoncu, Rushika M. Perera
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 817-827
Closed Access | Times Cited: 15
Roberto Zoncu, Rushika M. Perera
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 817-827
Closed Access | Times Cited: 15
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, et al.
The Oncologist (2023) Vol. 28, Iss. 5, pp. 433-439
Open Access | Times Cited: 14
Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, et al.
The Oncologist (2023) Vol. 28, Iss. 5, pp. 433-439
Open Access | Times Cited: 14
Hidekazu Nishizawa, Shintaro Funasaki, Wenjuan Ma, et al.
Genes to Cells (2025) Vol. 30, Iss. 1
Open Access
Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
Yasser Ged, Amina Touma, Luis Contreras, et al.
Journal of Immunotherapy (2025) Vol. 48, Iss. 3, pp. 113-117
Closed Access
Yasser Ged, Amina Touma, Luis Contreras, et al.
Journal of Immunotherapy (2025) Vol. 48, Iss. 3, pp. 113-117
Closed Access
CDK4/6 inhibition with Abemaciclib in patients with previously treated advanced renal cell carcinoma
Bradley A. McGregor, Wanling Xie, Stephanie Berg, et al.
Clinical Genitourinary Cancer (2025) Vol. 23, Iss. 3, pp. 102318-102318
Closed Access
Bradley A. McGregor, Wanling Xie, Stephanie Berg, et al.
Clinical Genitourinary Cancer (2025) Vol. 23, Iss. 3, pp. 102318-102318
Closed Access
Metastatic MiT family/TFE translocation renal cell carcinoma in adults: case series reports and literature reviews
Xueru Sun, Hong Wang, Xiuyue Man, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Xueru Sun, Hong Wang, Xiuyue Man, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma
Alexandra Helleux, Guillaume Davidson, Antonin Lallement, et al.
EMBO Molecular Medicine (2025)
Open Access
Alexandra Helleux, Guillaume Davidson, Antonin Lallement, et al.
EMBO Molecular Medicine (2025)
Open Access
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma
Choon Leng So, Ye Jin Lee, Bujamin Vokshi, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115539-115539
Open Access
Choon Leng So, Ye Jin Lee, Bujamin Vokshi, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115539-115539
Open Access
RNA polymerase II partitioning is a shared feature of diverse oncofusion condensates
Heankel Lyons, Prashant Pradhan, Gopinath Prakasam, et al.
Cell (2025)
Closed Access
Heankel Lyons, Prashant Pradhan, Gopinath Prakasam, et al.
Cell (2025)
Closed Access
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
Audrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7649-7649
Open Access | Times Cited: 17
Audrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7649-7649
Open Access | Times Cited: 17
MiT/TFE Family Renal Cell Carcinoma
Jinglong Tang, Masaya Baba
Genes (2023) Vol. 14, Iss. 1, pp. 151-151
Open Access | Times Cited: 10
Jinglong Tang, Masaya Baba
Genes (2023) Vol. 14, Iss. 1, pp. 151-151
Open Access | Times Cited: 10
The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma
Priyanka Naik, Harshitha Dudipala, Yu‐Wei Chen, et al.
Therapeutic Advances in Urology (2024) Vol. 16
Open Access | Times Cited: 3
Priyanka Naik, Harshitha Dudipala, Yu‐Wei Chen, et al.
Therapeutic Advances in Urology (2024) Vol. 16
Open Access | Times Cited: 3
ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs
Ewa Sicinska, Vijaya S.R. Kola, Joseph A. Kerfoot, et al.
Cancer Research (2024) Vol. 84, Iss. 14, pp. 2247-2264
Closed Access | Times Cited: 3
Ewa Sicinska, Vijaya S.R. Kola, Joseph A. Kerfoot, et al.
Cancer Research (2024) Vol. 84, Iss. 14, pp. 2247-2264
Closed Access | Times Cited: 3
Huayi Feng, Shouqing Cao, Shihui Fu, et al.
The Journal of Pathology (2024) Vol. 264, Iss. 2, pp. 228-240
Open Access | Times Cited: 3
